Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease

NCT00489827 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT00489827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
August 31, 2022
Enrollment
865 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass, coronary artery disease, myocardial infarction, myocardial ischemia